pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopaatiline kopsufibroos - immunosupressandid - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
kisplyx
eisai gmbh - lenvatinibmesülaat - kartsinoom, neerurakk - antineoplastilised ained - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
anafranil kaetud tablett
pharmaand gmbh - klomipramiin - kaetud tablett - 25mg 30tk
anafranil sr toimeainet prolongeeritult vabastav tablett
pharmaand gmbh - klomipramiin - toimeainet prolongeeritult vabastav tablett - 75mg 20tk
anafranil kaetud tablett
pharmaand gmbh - klomipramiin - kaetud tablett - 10mg 30tk
pirfenidone teva õhukese polümeerikattega tablett
teva gmbh - pirfenidoon - õhukese polümeerikattega tablett - 801mg 252tk; 801mg 84tk
pirfenidone teva õhukese polümeerikattega tablett
teva gmbh - pirfenidoon - õhukese polümeerikattega tablett - 267mg 252tk
axhidrox kreem
dr. august wolff gmbh & co. kg arzneimittel - glükopürroonium - kreem - 8mg 1g 50g 1tk
sartens plus 100/25 mg õhukese polümeerikattega tablett
g.l. pharma gmbh - losartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 100mg+25mg 28tk; 100mg+25mg 280tk; 100mg+25mg 7tk; 100mg+25mg 100tk; 100mg+25mg 10tk
sartens plus 50/12,5 mg õhukese polümeerikattega tablett
g.l. pharma gmbh - losartaan+hüdroklorotiasiid - õhukese polümeerikattega tablett - 50mg+12,5mg 50tk; 50mg+12,5mg 56tk; 50mg+12,5mg 30tk; 50mg+12,5mg 14tk; 50mg+12,5mg 100tk; 50mg+12,5mg 280tk; 50mg+12,5mg 28tk; 50mg+12,5mg 10tk